Cystic fibrosis in adults: current and future management strategies.
Over 30,000 individuals in the United States of America are living with cystic fibrosis (CF). Despite incremental advances in care and understanding of its pathophysiology, CF remains a significantly life-limiting disease. Readily accessible newborn screening, genetic testing, and an improved awareness have increased the early recognition of CF, atypical presentations of CF, and the CF-related diseases. Improvements in medical management have led to continually improving life expectancy for patients with CF. Despite improved management strategies, severe lung disease remains the commonly life-limiting pathology. We review the pathophysiology, diagnosis, and management of the respiratory-tract manifestations of CF that represent the life-limiting aspects of the condition and summarize upcoming and possible future therapies for patients with CF.
Morrissey
Brian M
BM
Adult Cystic Fibrosis Clinic and University of California Davis School of Medicine, Sacramento, CA, USA. bmmorrissey@ucdavis.edu
Schock
Bettina C
BC
Marelich
Gregory P
GP
Cross
Carroll E
CE
D000328:Adult; D003550:Cystic Fibrosis / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy* / Q000821:virology; D004783:Environmental Microbiology; D015316:Genetic Therapy; D006801:Humans; D016040:Lung Transplantation; D016106:Methicillin Resistance